openPR Logo
Press release

Osteoarthritis Treatment Market to Set Phenomenal Growth by 2025 | Top International Players - Pfizer, Novartis, GlaxoSmithKline, Zimmer Biomet, Stryker, Abbott

04-01-2020 05:33 AM CET | Health & Medicine

Press release from: Business Industry Reports

/ PR Agency: Business Industry Reports
Osteoarthritis Treatment Market

Osteoarthritis Treatment Market

This report provides in depth study of "Osteoarthritis Treatment Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Osteoarthritis Treatment Market report also provides an in-depth survey of key players in the market organization.

Global Osteoarthritis Treatment Market overview:

BusinessIndustryReports have new report spread across 96 pages is an overview of the Global Osteoarthritis Treatment Market Report 2020. The Global Osteoarthritis Treatment Market is projected to grow at a healthy growth rate from 2020 to 2024 according to new research. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/248762

With the slowdown in world economic growth, due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market

On the basis of Product Type, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Drugs, Assistive Devices. The viscosupplementation agents segment accounted for the largest market share in 2018. The rising incidence and prevalence of knee osteoarthritis are supporting their adoption in the market. Based on End Users/Applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Asia Pacific was a prominent market for Osteoarthritis Treatments in 2016. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India. These countries have been witnessing rapid increase in its population along with expansion of their overall economies, which has led to increase in disposable income. Increased spending on home interiors is fuelling the Osteoarthritis Treatment market in Asia Pacific.

There are several manufacturers of Osteoarthritis Treatments in Europe and North America. In North America, the demand for Osteoarthritis Treatments is primarily driven by the residential sector. Improved standards of living and rising usage of Osteoarthritis Treatments for flooring purpose are anticipated to drive the market in North America.

In Europe, the demand for Osteoarthritis Treatment is anticipated to be primarily from the commercial sector. Osteoarthritis Treatments are being employed widely for flooring in commercial complexes, which is estimated be a major factor that is likely to propelling the consistent expansion of the Osteoarthritis Treatment market in the region.

Some of the major players that operate in the Global Osteoarthritis Treatment Market are Pfizer, Johnson & Johnson, Novartis, GlaxoSmithKline, Zimmer Biomet, Stryker, Abbott.

Latest Industry Updates:

NEW YORK & INDIANAPOLIS--(BUSINESS WIRE)-- Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg. The objective of the study was to compare the long-term joint safety and 16-week efficacy of tanezumab relative to nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with moderate-to-severe osteoarthritis (OA) of the hip or knee.

The tanezumab 5 mg treatment arm met two of the three co-primary efficacy endpoints, demonstrating a statistically significant improvement in pain and physical function compared to NSAIDs at the 16-week analysis, while patients' overall assessment of their OA was not statistically different than NSAIDs. Patients who received tanezumab 2.5 mg did not experience a statistically significant improvement in pain, physical function or patients' overall assessment of their OA at 16 weeks compared to NSAIDs. In the safety analysis, there was a higher rate of joint safety events in the tanezumab arms compared to NSAIDs at 80 weeks; the difference was statistically significant.

Joint safety was a composite measure consisting of adjudicated outcomes of rapidly progressive osteoarthritis (RPOA) type 1 or type 2, subchondral insufficiency fracture, osteonecrosis or pathological fracture. Tanezumab is a monoclonal antibody that is part of an investigational class of non-opioid chronic pain medications known as nerve growth factor (NGF) inhibitors.

Buy Osteoarthritis Treatment Market analysis & forecast 2020-2024 Report along with complete TOC@ https://www.businessindustryreports.com/buy-now/248762/single

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of HD Map in these regions, from 2013 to 2024 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Get Attractive Discount @ https://www.businessindustryreports.com/check-discount/248762

Table of Contents:

Section 1 Osteoarthritis Treatment Product Definition

Section 2 Global Osteoarthritis Treatment Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Osteoarthritis Treatment Shipments

2.2 Global Manufacturer Osteoarthritis Treatment Business Revenue

2.3 Global Osteoarthritis Treatment Market Overview

Section 3 Manufacturer Osteoarthritis Treatment Business Introduction

3.1 Occucare International Osteoarthritis Treatment Business Introduction

3.1.1 Occucare International Osteoarthritis Treatment Shipments, Price, Revenue and Gross profit 2014-2019

3.1.2 Occucare International Osteoarthritis Treatment Business Distribution by Region

3.1.3 Occucare International Interview Record

3.1.4 Occucare International Osteoarthritis Treatment Business Profile

3.1.5 Occucare International Osteoarthritis Treatment Product Specification

3.2 HCA Healthcare Osteoarthritis Treatment Business Introduction

3.2.1 HCA Healthcare Osteoarthritis Treatment Shipments, Price, Revenue and Gross profit 2014-2019

3.2.2 HCA Healthcare Osteoarthritis Treatment Business Distribution by Region

3.2.3 Interview Record

3.2.4 HCA Healthcare Osteoarthritis Treatment Business Overview

3.2.5 HCA Healthcare Osteoarthritis Treatment Product Specification

3.3 Concentra Operating Osteoarthritis Treatment Business Introduction

3.3.1 Concentra Operating Osteoarthritis Treatment Shipments, Price, Revenue and Gross profit 2014-2019

3.3.2 Concentra Operating Osteoarthritis Treatment Business Distribution by Region

3.3.3 Interview Record

3.3.4 Concentra Operating Osteoarthritis Treatment Business Overview

3.3.5 Concentra Operating Osteoarthritis Treatment Product Specification

TOC continue.............................

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteoarthritis Treatment Market to Set Phenomenal Growth by 2025 | Top International Players - Pfizer, Novartis, GlaxoSmithKline, Zimmer Biomet, Stryker, Abbott here

News-ID: 1993777 • Views:

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo International, Nuvo Pharma, Ferndale Pharma, Galen, Jazz Pharma, Paladin Labs, St Renatus, MSK Pharma
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Lockheed Martin, BAE System, Boeing, General Dynamic, Raytheon) | Forecast to 2025
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growth by Top Key Company’s - J&J, Medtronic, B Braun, Boston Medical, Integra, Stryker, Zimmer, CONMED
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key Players - Apple, Fitbit, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Osteoarthritis

Osteoarthritis Therapeutics Market: Rising Obese and Geriatric Populations to In …
Industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. What the Osteoarthritis Therapeutics Market Looks Like? The osteoarthritis therapeutics market is projected to reach USD 10.1 billion by 2024 from USD 6.8
Osteoarthritis Treatment Market by Product (Drugs, Hyaluronic acid Injection) by …
Global Osteoarthritis Treatment Market was valued at USD XX Billion in the year 2017. Global Osteoarthritis Treatment Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023. Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE369 North America region holds the highest market share in 2017 and is considered as the fastest growing market in the forecasted period. At a
Osteoarthritis-Pipeline Review H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis-Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint
Osteoarthritis - Pipeline Review, H2 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older
Osteoarthritis - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H1 2017, provides an overview of the Osteoarthritis (Immunology) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries
Osteoarthritis-Pipeline by Review H2 2017
ReportsWeb.com has announced the addition of the “Osteoarthritis-Pipeline Review H2 2017” this report provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries